Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract
- 1 August 2014
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 71 (2) , 229-236
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- Multiplex Mutation Screening by Mass SpectrometryThe Journal of Molecular Diagnostics, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other SitesClinical Cancer Research, 2011
- KIT as a Therapeutic Target in Metastatic MelanomaJAMA, 2011
- Mutations inGNA11in Uveal MelanomaNew England Journal of Medicine, 2010
- Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KITBritish Journal of Cancer, 2010
- BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naeviBritish Journal of Dermatology, 2009
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomasBritish Journal of Cancer, 2008